Emmaus Life Sciences Inc (EMMA)
OTHER OTC:EMMA
US Market

Emmaus Life Sciences (EMMA) Stock Price & Analysis

82 Followers

EMMA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.07 - $0.60
Previous Close$0.31
Volume832.00
Average Volume (3M)12.64K
Market Cap
$14.21M
Enterprise Value$47.86M
Total Cash (Recent Filing)$1.77M
Total Debt (Recent Filing)$33.00M
Price to Earnings (P/E)-1.2
Beta0.88
Aug 14, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.25
Shares Outstanding53,637,554
10 Day Avg. Volume6,965
30 Day Avg. Volume12,636
Standard Deviation0.38
R-Squared0.13
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)-0.29
Price to Sales (P/S)2.46
Price to Cash Flow (P/CF)-2.90
P/FCF Ratio16.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.18
Enterprise Value/Gross Profit3.03
Enterprise Value/Ebitda-14.99
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.

---

EMMA FAQ

What was Emmaus Life Sciences Inc’s price range in the past 12 months?
Emmaus Life Sciences Inc lowest stock price was $0.07 and its highest was $0.60 in the past 12 months.
    What is Emmaus Life Sciences Inc’s market cap?
    Currently, no data Available
    When is Emmaus Life Sciences Inc’s upcoming earnings report date?
    Emmaus Life Sciences Inc’s upcoming earnings report date is Aug 14, 2023 which is in 75 days.
      How were Emmaus Life Sciences Inc’s earnings last quarter?
      Currently, no data Available
      Is Emmaus Life Sciences Inc overvalued?
      According to Wall Street analysts Emmaus Life Sciences Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Emmaus Life Sciences Inc pay dividends?
        Emmaus Life Sciences Inc does not currently pay dividends.
        What is Emmaus Life Sciences Inc’s EPS estimate?
        Emmaus Life Sciences Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Emmaus Life Sciences Inc have?
        Emmaus Life Sciences Inc has 53,637,554 shares outstanding.
          What happened to Emmaus Life Sciences Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Emmaus Life Sciences Inc?
          Currently, no hedge funds are holding shares in EMMA

          ---

          Emmaus Life Sciences Stock Smart Score

          N/A
          Not Ranked
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Technicals

          SMA
          Negative
          20 days / 200 days
          Momentum
          -11.42%
          12-Months-Change

          Fundamentals

          Return on Equity
          Trailing 12-Months
          Asset Growth
          -4.95%
          Trailing 12-Months
          This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
          Learn more about TipRanks Smart Score

          Company Description

          Emmaus Life Sciences Inc

          Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company. It engages in the discovery, development, marketing and sale of innovative treatments and therapies, including those in the rare and orphan disease categories. The company is headquartered in Torrance, CA.

          ---

          Forecast EPS vs Actual EPS

          Currently, no data available
          Please return soon. This page is being updated.

          Similar Stocks
          Company
          Price & Change
          Follow
          Context Therapeutics
          9 Meters Biopharma
          Cocrystal Pharma
          Novan
          Clever Leaves Holdings

          Popular Stocks

          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis